{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T22:13:52Z","timestamp":1787004832312,"version":"build-2736575974"},"reference-count":77,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["seminperinat.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Perinatology"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1053\/j.semperi.2015.11.006","type":"journal-article","created":{"date-parts":[[2015,12,24]],"date-time":"2015-12-24T23:45:15Z","timestamp":1451000715000},"page":"35-43","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Screening for fetal aneuploidy"],"prefix":"10.1053","volume":"40","author":[{"given":"Britton D.","family":"Rink","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary E.","family":"Norton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1053\/j.semperi.2015.11.006_bib1","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/pd.1443","article-title":"Maternal age-specific fetal loss rates in Down syndrome pregnancies","volume":"26","author":"Savva","year":"2006","journal-title":"Prenat Diagn"},{"issue":"13","key":"10.1053\/j.semperi.2015.11.006_bib2","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1056\/NEJM199103283241302","article-title":"Parental origin of the extra chromosome in trisomy 21 as indicated by analysis of DNA polymorphisms. Down Syndrome Collaborative Group","volume":"324","author":"Antonarakis","year":"1991","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1053\/j.semperi.2015.11.006_bib3","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/00006250-200701000-00054","article-title":"Screening for fetal chromosomal abnormalities","volume":"109","author":"ACOG Practice Bulletin No. 77","year":"2007","journal-title":"Obstet Gynecol"},{"issue":"10","key":"10.1053\/j.semperi.2015.11.006_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/pd.4601","article-title":"Overview of the impact of noninvasive prenatal testing on diagnostic procedures","volume":"35","author":"Warsof","year":"2015","journal-title":"Prenat Diagn"},{"issue":"6831","key":"10.1053\/j.semperi.2015.11.006_bib5","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1136\/bmj.304.6831.867","article-title":"Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy","volume":"304","author":"Nicolaides","year":"1992","journal-title":"Br Med J"},{"issue":"2","key":"10.1053\/j.semperi.2015.11.006_bib6","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1258\/096914103321824133","article-title":"First and second trimester antenatal screening for Down\u2019s syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS)","volume":"10","author":"Wald","year":"2003","journal-title":"J Med Screen"},{"issue":"19","key":"10.1053\/j.semperi.2015.11.006_bib7","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa043693","article-title":"First- and Second-Trimester Evaluation of Risk (FASTER) Research Consortium. First-trimester or second-trimester screening, or both, for Down\u2019s syndrome","volume":"353","author":"Malone","year":"2005","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1053\/j.semperi.2015.11.006_bib8","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1056\/NEJMoa025273","article-title":"First-trimester screening for trisomies 21 and 18","volume":"349","author":"Wapner","year":"2003","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1053\/j.semperi.2015.11.006_bib9","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/01.AOG.0000173318.54978.1f","article-title":"First-trimester septated cystic hygroma: prevalence, natural history and pediatric outcome","volume":"106","author":"Malone","year":"2005","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1053\/j.semperi.2015.11.006_bib10","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1097\/01.AOG.0000201979.23031.32","article-title":"Cystic hygroma, nuchal edema and nuchal translucency at 11-14 weeks of gestation","volume":"107","author":"Molina","year":"2006","journal-title":"Obstet Gynecol"},{"issue":"6","key":"10.1053\/j.semperi.2015.11.006_bib11","doi-asserted-by":"crossref","first-page":"675e1","DOI":"10.1016\/j.ajog.2014.06.025","article-title":"Risk of selected structural abnormalities in infants after increased nuchal translucency measurement","volume":"211","author":"Baer","year":"2014","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1053\/j.semperi.2015.11.006_bib12","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1067\/S0002-9378(03)00645-8","article-title":"Screening performance of first-trimester nuchal translucency for major cardiac defects: a meta-analysis","volume":"189","author":"Makrydimas","year":"2003","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1053\/j.semperi.2015.11.006_bib13","doi-asserted-by":"crossref","first-page":"518e1","DOI":"10.1016\/j.ajog.2014.10.1102","article-title":"Risk of critical congenital heart defects by nuchal translucency norms","volume":"212","author":"Jelliffe-Pawlowski","year":"2015","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1053\/j.semperi.2015.11.006_bib14","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1046\/j.1469-0705.1999.13040231.x","article-title":"A screening program for trisomy 21 at 10\u201314 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A","volume":"13","author":"Spencer","year":"1999","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"9","key":"10.1053\/j.semperi.2015.11.006_bib15","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/(SICI)1097-0223(199709)17:9<821::AID-PD154>3.0.CO;2-5","article-title":"Combining ultrasound and biochemistry in first-trimester screening for Down syndrome","volume":"17","author":"Wald","year":"1997","journal-title":"Prenat Diagn"},{"issue":"5","key":"10.1053\/j.semperi.2015.11.006_bib16","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1097\/01.AOG.0000241095.19638.f2","article-title":"Comparison of serum markers in first-trimester Down syndrome screening","volume":"108","author":"Canick","year":"2006","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1053\/j.semperi.2015.11.006_bib17","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ajog.2004.03.090","article-title":"Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities","volume":"191","author":"Nicolaides","year":"2004","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1053\/j.semperi.2015.11.006_bib18","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/uog.4044","article-title":"Increased nuchal translucency thickness and normal karyotype: time for parental reassurance","volume":"30","author":"Bilrdo","year":"2007","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"4","key":"10.1053\/j.semperi.2015.11.006_bib19","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.ajog.2004.12.093","article-title":"Increased nuchal translucency with normal karyotype","volume":"192","author":"Souka","year":"2005","journal-title":"Am J Obstet Gynecol"},{"issue":"9125","key":"10.1053\/j.semperi.2015.11.006_bib20","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0140-6736(97)11280-6","article-title":"A multicentre project on assessment of risk for trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks gestation. Fetal Medicine Foundation First Trimester screening Group","volume":"352","author":"Snijders","year":"1998","journal-title":"Lancet"},{"issue":"3","key":"10.1053\/j.semperi.2015.11.006_bib21","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/uog.992","article-title":"Likelihood ratio for trisomy 21 in fetuses with absent nasal bone at the 11\u201314-week scan","volume":"23","author":"Cicero","year":"2004","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"5","key":"10.1053\/j.semperi.2015.11.006_bib22","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/uog.10051","article-title":"First trimester screening for chromosomal abnormalities by integrated application of nuchal translucency, nasal bone, tricuspid regurgitation and ductus venosus flow combined with maternal serum free-beta hCG and PAPP-A: a 5-year prospective study","volume":"39","author":"Ghaffari","year":"2012","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1053\/j.semperi.2015.11.006_bib23","series-title":"Prenatal Diagnosis and Screening","first-page":"556","article-title":"Biochemical screening","author":"Wald","year":"1992"},{"issue":"7","key":"10.1053\/j.semperi.2015.11.006_bib24","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/0002-9378(84)90530-1","article-title":"An association between low maternal serum alpha-fetoprotein and fetal chromosome abnormalities","volume":"148","author":"Merkatz","year":"1984","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1053\/j.semperi.2015.11.006_bib25","first-page":"407","article-title":"Cord serum alpha-fetoprotein and Down syndrome","volume":"93","author":"Cuckle","year":"1986","journal-title":"Br J Obstet Gynaecol"},{"issue":"7781","key":"10.1053\/j.semperi.2015.11.006_bib26","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S0140-6736(72)92144-7","article-title":"Low urinary oestriol excretion during pregnancy in women giving birth to infants with Down syndrome","volume":"2","author":"Jorgensen","year":"1972","journal-title":"Lancet"},{"issue":"9","key":"10.1053\/j.semperi.2015.11.006_bib27","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/pd.1970070904","article-title":"Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetal chromosome abnormalities","volume":"7","author":"Bogart","year":"1987","journal-title":"Prenat Diagn"},{"issue":"2","key":"10.1053\/j.semperi.2015.11.006_bib28","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1177\/096914139600300202","article-title":"Second trimester levels of maternal serum inhibin A, total inhibin, alpha inhibin precursor, and activin in Down syndrome pregnancy","volume":"3","author":"Lambert-Messerlian","year":"1996","journal-title":"J Med Screening"},{"issue":"1","key":"10.1053\/j.semperi.2015.11.006_bib29","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1046\/j.1365-2265.1996.544368.x","article-title":"Second trimester screening for Down syndrome using maternal serum dimeric inhibin A","volume":"44","author":"Wallace","year":"1996","journal-title":"Clin Endocrinol"},{"issue":"4","key":"10.1053\/j.semperi.2015.11.006_bib30","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1053\/j.semperi.2005.05.011","article-title":"Second trimester serum markers","volume":"29","author":"Canick","year":"2005","journal-title":"Semin Perinatol"},{"issue":"4","key":"10.1053\/j.semperi.2015.11.006_bib31","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1177\/096914139700400402","article-title":"Antenatal screening for Down\u2019s syndrome","volume":"4","author":"Wald","year":"1997","journal-title":"J Med Screen"},{"issue":"suppl","key":"10.1053\/j.semperi.2015.11.006_bib32","first-page":"227","article-title":"Prospective trial of a screening protocol to identify trisomy 18 using maternal serum alpha-fetoprotein, unconjugated estriol, and human chorionic gonadotropin","volume":"49","author":"Palomaki","year":"1991","journal-title":"Prenat Diagn"},{"issue":"10","key":"10.1053\/j.semperi.2015.11.006_bib33","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/(SICI)1097-0223(199608)16:8<691::AID-PD946>3.0.CO;2-2","article-title":"Effect of allowing for ethnic group in prenatal screening for Down\u2019s syndrome","volume":"16","author":"Watt","year":"1996","journal-title":"Prenat Diagn"},{"issue":"6","key":"10.1053\/j.semperi.2015.11.006_bib34","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/1097-0223(200006)20:6<491::AID-PD844>3.0.CO;2-3","article-title":"The influence of ethnic origin on first trimester biochemical markers of chromosomal abnormalities","volume":"20","author":"Spencer","year":"2000","journal-title":"Prenat Diagn"},{"issue":"10","key":"10.1053\/j.semperi.2015.11.006_bib35","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/pd.994","article-title":"Second-trimester prenatal screening markers for Down syndrome in women with insulin-dependent diabetes mellitus","volume":"24","author":"Huttly","year":"2004","journal-title":"Prenat Diagn"},{"issue":"12","key":"10.1053\/j.semperi.2015.11.006_bib36","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1111\/j.1471-0528.1999.tb08186.x","article-title":"Serum markers for Down\u2019s syndrome in women who have had in vitro fertilization: implications for antenatal screening","volume":"106","author":"Wald","year":"1999","journal-title":"Br J Obstet Gynaecol"},{"issue":"4","key":"10.1053\/j.semperi.2015.11.006_bib37","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1053\/j.semperi.2005.05.004","article-title":"Down syndrome screening in the first and\/or second trimester: model predicted performance using meta-analysis parameters","volume":"29","author":"Cuckle","year":"2005","journal-title":"Semin Perinatol"},{"issue":"1","key":"10.1053\/j.semperi.2015.11.006_bib38","first-page":"17","article-title":"Pregnancy outcomes after increasing levels of maternal serum alpha-fetoprotein","volume":"74","author":"Robinson","year":"1989","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1053\/j.semperi.2015.11.006_bib39","first-page":"693","article-title":"Placenta accreta, percreta and increta: a cause of increased maternal serum alpha-fetoprotein","volume":"80","author":"Zelop","year":"1992","journal-title":"Obstet Gynecol"},{"issue":"7","key":"10.1053\/j.semperi.2015.11.006_bib40","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/(SICI)1097-0223(199607)16:7<635::AID-PD923>3.0.CO;2-V","article-title":"Uterine malformation: a cause of elevated maternal serum alpha-fetoprotein concentrations","volume":"16","author":"Heinonen","year":"1996","journal-title":"Prenat Diagn"},{"issue":"1","key":"10.1053\/j.semperi.2015.11.006_bib41","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1046\/j.1469-0705.1999.13010058.x","article-title":"Perinatal outcome in pregnancies with a positive serum screening for Down\u2019s syndrome due to elevated levels of free beta-human chorionic gonadotropin","volume":"13","author":"Palacio","year":"1999","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"2","key":"10.1053\/j.semperi.2015.11.006_bib42","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/01.AOG.0000172419.37410.eb","article-title":"FASTER Trial Research Consortium. Quad screen as a predictor of adverse pregnancy outcome","volume":"106","author":"Dugoff","year":"2005","journal-title":"Obstet Gynecol"},{"issue":"5","key":"10.1053\/j.semperi.2015.11.006_bib43","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1067\/mob.2003.278","article-title":"Association between second-trimester isolated high maternal serum maternal serum human chorionic gonadotropin levels and obstetric complications in singleton and twin pregnancies","volume":"188","author":"Lepage","year":"2003","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1053\/j.semperi.2015.11.006_bib44","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0020-7292(96)02830-5","article-title":"Elevated second trimester human chorionic gonadotropin level associated with adverse pregnancy outcome","volume":"56","author":"Onderoglu","year":"1997","journal-title":"Int J Gynaecol Obstet"},{"issue":"1","key":"10.1053\/j.semperi.2015.11.006_bib45","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0301-2115(03)00081-2","article-title":"Second trimester total human chorionic gonadotropin, alpha-fetoprotein and unconjugated estriol in predicting pregnancy complications other than fetal aneuploidy","volume":"110","author":"Duric","year":"2003","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"3","key":"10.1053\/j.semperi.2015.11.006_bib46","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S0029-7844(97)00677-7","article-title":"Association of low unconjugated estriol in the second trimester and adverse pregnancy outcome","volume":"91","author":"Kowalczyk","year":"1998","journal-title":"Obstet Gynecol"},{"key":"10.1053\/j.semperi.2015.11.006_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-3101(23)00093-2","article-title":"Inborn errors of cholesterol biosynthesis","volume":"47","author":"Kelley","year":"2000","journal-title":"Adv Pediatr"},{"issue":"5","key":"10.1053\/j.semperi.2015.11.006_bib48","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/(SICI)1096-8628(19990219)82:5<376::AID-AJMG4>3.0.CO;2-B","article-title":"Prenatal diagnosis of the RSH\/Smith-Lemli-Opitz syndrome","volume":"82","author":"Kratz","year":"1999","journal-title":"Am J Med Genet"},{"issue":"1","key":"10.1053\/j.semperi.2015.11.006_bib49","first-page":"167","article-title":"Maternal serum unconjugated estriol as a predictor for Smith-Lemli-Opitz syndrome and other fetal conditions","volume":"102","author":"Schoen","year":"2003","journal-title":"Obstet Gynecol"},{"issue":"11","key":"10.1053\/j.semperi.2015.11.006_bib50","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1002\/pd.466","article-title":"Low or absent unconjugated estriol in pregnancy: an indicator for steroid sulfatase deficiency detectable by fluorescence in situ hybridization and biochemical analysis","volume":"22","author":"Kashork","year":"2002","journal-title":"Prenat Diagn"},{"issue":"3","key":"10.1053\/j.semperi.2015.11.006_bib51","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0002-9378(97)70542-8","article-title":"Undetectable maternal serum unconjugated estriol levels in the second trimester: risk of perinatal complications associated with placental sulfatase deficiency","volume":"176","author":"Bradley","year":"1997","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1053\/j.semperi.2015.11.006_bib52","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1097\/AOG.0b013e3181da93da","article-title":"First and second-trimester maternal serum markers for aneuploidy and adverse obstetric outcomes","volume":"115","author":"Dugoff","year":"2010","journal-title":"Obstet Gynecol"},{"issue":"6","key":"10.1053\/j.semperi.2015.11.006_bib53","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1097\/AOG.0b013e3181c15064","article-title":"Role of second-trimester genetic sonography after Down syndrome screening","volume":"114","author":"Aagaard-Tillery","year":"2009","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1053\/j.semperi.2015.11.006_bib54","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/uog.12364","article-title":"Meta-analysis of second trimester markers for trisomy 21","volume":"41","author":"Agathokleous","year":"2013","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"7606","key":"10.1053\/j.semperi.2015.11.006_bib55","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0140-6736(69)91642-0","article-title":"Practical and theoretical implications of fetal\u2013maternal lymphocyte transfer","volume":"1","author":"Walknowska","year":"1969","journal-title":"Lancet"},{"issue":"9067","key":"10.1053\/j.semperi.2015.11.006_bib56","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0140-6736(97)02174-0","article-title":"Presence of fetal DNA in maternal plasma and serum","volume":"350","author":"Lo","year":"1997","journal-title":"Lancet"},{"issue":"2","key":"10.1053\/j.semperi.2015.11.006_bib57","doi-asserted-by":"crossref","first-page":"137e1","DOI":"10.1016\/j.ajog.2012.05.021","article-title":"Non-Invasive Chromosomal Evaluation (NICE) Study: results of a multi-center prospective cohort study for detection of fetal trisomy 21 and trisomy 18","volume":"207","author":"Norton","year":"2012","journal-title":"Am J Obstet Gynecol"},{"issue":"9","key":"10.1053\/j.semperi.2015.11.006_bib58","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1373\/clinchem.2005.051235","article-title":"Optimized real-time quantitative PCR measurement of male fetal DNA in maternal plasma","volume":"51","author":"Zimmermann","year":"2005","journal-title":"Clin Chem"},{"issue":"3","key":"10.1053\/j.semperi.2015.11.006_bib59","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1586\/erm.10.5","article-title":"Noninvasive fetal RhD genotyping from maternal blood","volume":"10","author":"Kolialexi","year":"2010","journal-title":"Expert Rev Mol Diagn"},{"issue":"6","key":"10.1053\/j.semperi.2015.11.006_bib60","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1097\/01.AOG.0000423819.85283.f4","article-title":"American College of Obstetricians and Gynecologists. Noninvasive prenatal testing for fetal aneuploidy","volume":"120","author":"Committee Opinion No. 545","year":"2012","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1053\/j.semperi.2015.11.006_bib61","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1093\/humupd\/dmt001","article-title":"Noninvasive detection of fetal trisomy 21: systematic review and report of quality and outcomes of diagnostic accuracy studies performed between 1997 and 2012","volume":"19","author":"Mersy","year":"2013","journal-title":"Human Reprod Update"},{"issue":"13","key":"10.1053\/j.semperi.2015.11.006_bib62","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1002\/pd.4002","article-title":"Clinical application of massively parallel sequencing-based prenatal noninvasive fetal trisomy test for trisomies 21 and 18 in 11,105 pregnancies with mixed risk factors","volume":"32","author":"Dan","year":"2012","journal-title":"Prenat Diagn"},{"issue":"9","key":"10.1053\/j.semperi.2015.11.006_bib63","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1056\/NEJMoa1311037","article-title":"DNA sequencing versus standard prenatal aneuploidy screening","volume":"370","author":"Bianchi","year":"2014","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1053\/j.semperi.2015.11.006_bib64","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1097\/AOG.0b013e31828642c6","article-title":"Noninvasive prenatal testing for fetal aneuploidy: clinical assessment and a plea for restraint","volume":"121","author":"Norton","year":"2013","journal-title":"Obstet Gynecol"},{"issue":"17","key":"10.1053\/j.semperi.2015.11.006_bib65","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1056\/NEJMoa1407349","article-title":"Cell-free DNA analysis for noninvasive examination of trisomy","volume":"372","author":"Norton","year":"2015","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1053\/j.semperi.2015.11.006_bib66","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1097\/AOG.0000000000000452","article-title":"Chromosome abnormalities detected by current prenatal screening and noninvasive prenatal testing","volume":"124","author":"Norton","year":"2014","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1053\/j.semperi.2015.11.006_bib67","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3109\/14767058.2012.722731","article-title":"The fetal fraction of cell-free DNA in maternal plasma is not affected by a priori of fetal trisomy","volume":"26","author":"Brar","year":"2013","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"2 Pt 1","key":"10.1053\/j.semperi.2015.11.006_bib68","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/AOG.0000000000000363","article-title":"Single-nucleotide polymorphism-based noninvasive prenatal screening in a high-risk and low-risk cohort","volume":"124","author":"Pergament","year":"2014","journal-title":"Obstet Gynecol"},{"issue":"23","key":"10.1053\/j.semperi.2015.11.006_bib69","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1056\/NEJMoa1203382","article-title":"Chromosomal microarray versus karyotyping for prenatal diagnosis","volume":"367","author":"Wapner","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semperi.2015.11.006_bib70","doi-asserted-by":"crossref","first-page":"e93559","DOI":"10.1371\/journal.pone.0093559","article-title":"Model-based analysis of costs and outcomes of non-invasive prenatal testing for Down\u2019s Syndrome using cell free fetal DNA in the UK National Health Service","volume":"9","author":"Morris","year":"2014","journal-title":"PloS One"},{"issue":"7","key":"10.1053\/j.semperi.2015.11.006_bib71","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/pd.4157","article-title":"Maternal cfDNA screening for Down syndrome\u2014a cost sensitivity analysis","volume":"33","author":"Cuckle","year":"2013","journal-title":"Prenat Diagn"},{"issue":"7407","key":"10.1053\/j.semperi.2015.11.006_bib72","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/nature11251","article-title":"Non-invasive prenatal measurement of the fetal genome","volume":"487","author":"Fan","year":"2012","journal-title":"Nature"},{"issue":"7","key":"10.1053\/j.semperi.2015.11.006_bib73","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/1471-0528.12574","article-title":"Prevalence and risk of Down syndrome in monozygotic and dizygotic multiple pregnancies in Europe: implications for prenatal screening","volume":"121","author":"Boyle","year":"2014","journal-title":"BJOG"},{"issue":"6","key":"10.1053\/j.semperi.2015.11.006_bib74","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1053\/j.semperi.2005.08.005","article-title":"First trimester screening for Down syndrome in multiple pregnancy","volume":"29","author":"Cleary-Goldman","year":"2005","journal-title":"Semin Perinatol"},{"issue":"7","key":"10.1053\/j.semperi.2015.11.006_bib75","doi-asserted-by":"crossref","first-page":"5880592","DOI":"10.1002\/pd.627","article-title":"Combining nuchal translucency and serum markers in prenatal screening for Down syndrome in twin pregnancies","volume":"23","author":"Wald","year":"2003","journal-title":"Prenat Diagn"},{"issue":"5","key":"10.1053\/j.semperi.2015.11.006_bib76","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/pd.2669","article-title":"Model predicted Down syndrome detection rates for nuchal translucency screening in twin pregnancies","volume":"31","author":"Maymon","year":"2011","journal-title":"Prenat Diagn"},{"issue":"12","key":"10.1053\/j.semperi.2015.11.006_bib77","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/pd.2145","article-title":"Second-trimester Down syndrome maternal serum marker screening: a prospective study of 11,040 twin pregnancies","volume":"28","author":"Garchet-Beaudron","year":"2008","journal-title":"Prenat Diagn"}],"container-title":["Seminars in Perinatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146000515001603?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146000515001603?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T07:17:41Z","timestamp":1718263061000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0146000515001603"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":77,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S0146000515001603"],"URL":"https:\/\/doi.org\/10.1053\/j.semperi.2015.11.006","relation":{},"ISSN":["0146-0005"],"issn-type":[{"value":"0146-0005","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Screening for fetal aneuploidy","name":"articletitle","label":"Article Title"},{"value":"Seminars in Perinatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semperi.2015.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}